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PENGESANAN ANTIBODI ANTI-GIARDIA DALAM KALANGAN 





Giardiasis, yang disebabkan oleh Giardia lamblia telah dikenalpasti sebagai salah satu 
jangkitan protozoa usus di seluruh dunia. Oleh kerana penyakit ini disebarkan melalui 
laluan dubur-mulut dan berpotensi disebarkan secara zoonosis, pekerjaan seperti 
penternak lembu merupakan salah satu pekerjaan yang berisiko tinggi. Di Malaysia, 
prevalens giardiasis berkisar antara 0.2 hingga 20% dan jangkitan sering dikaitkan 
dengan kekurangan zat makanan terutama di kalangan kanak-kanak. Prevalens yang 
dilaporkan adalah disimpulkan berdasarkan kes-kes yang masih aktif, tanpa mengira 
mereka yang pernah terdedah kepada jangkitan dalam masa yang terdekat itu. Kajian 
keratan rentas ini dilakukan untuk menyiasat prevalens giardiasis dan kaitannya 
dengan pendedahan pekerjaan di kalangan petani lembu di Kelantan dan 
membandingkannya dengan kumpulan kajian lain, iaitu Orang Asli dan penderma 
darah. Sampel serum yang diperoleh daripada 90 peserta menjalani ujian imunosorben 
berkaitan enzim (ELISA) dalaman untuk pengesanan antibodi IgG anti-Giardia. Data 
sosiodemografi telah dianalisis menggunakan SPSS v24.0 (Microsoft Corporation, 
USA). ELISA dalaman dioptimumkan dengan parameter piawai seperti kepekatan 
antigen pelapisan sebanyak 10 µg/mL, pencairan serum 1:50 dan antibodi sekunder 
terkonjugasi HRP 1:6000. Seroprevalens Orang Asli, penderma darah dan petani 
masing-masing adalah 68.7%, 1% dan 27.7%. Terdapat perbezaan yang signifikan (P 
<0.001) antara seroprevalens Orang Asli dan petani. Tidak ada penemuan yang 
signifikan yang ditunjukkan antara pemboleh ubah demografi subjek dan bacaan 
xii 
 
ELISA OD450nm. Kesimpulannya, seropositiviti giardiasis lebih tinggi pada populasi 
endemik berbanding dengan sera populasi bukan endemik. Kajian lebih lanjut 
diperlukan untuk mengenal pasti factor-faktor yang berkemungkinan kepada risiko 
seropositiviti tersebut.  
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Giardiasis, caused by Giardia lamblia, has been recognized as one of the most 
common intestinal protozoan infections worldwide. As the disease is spread by the  
faecal-oral route and potentially zoonotic transmitted, occupations such as cattle 
farmers are one of the high-risk jobs. In Malaysia, the prevalence of giardiasis ranges 
between 0.2 to 20%, and infection is often associated with malnutrition particularly 
among children. The reported prevalence inferred only to active cases, but not the 
people who are exposed to the infection recently. This cross-sectional study was 
conducted to investigate the prevalence of giardiasis in relation to occupational 
exposure among cattle farmers in Kelantan and to compare it with other study groups, 
Orang Asli and blood donor. Achieved serum samples from 90 participants were 
subjected to an in-house enzyme-linked immunosorbent assay (ELISA) for the 
detection of anti-Giardia IgG antibody. Sociodemographic data were analysed using 
SPSS v24.0 (Microsoft Corporation, USA). An in-house ELISA was optimised with 
standardised parameters as such coating antigen concentration of 10 µg/mL, serum 
dilution of 1:50, and HRP-conjugated secondary antibody of 1:6000. The 
seroprevalence of Orang Asli, blood donors, and farmers were 68.7%, 1%, and 27.7% 
respectively. There were significant (P<0.001) difference between the seroprevalence 
of Orang Asli and farmers. There were no significant findings shown between 
subjects’ demographic variables and ELISA OD450nm reading. In conclusion, the 
seropositivity of giardiasis is higher in the endemic population as compared to the sera 
xiv 
 
of non-endemic population. Further study is required to identify the possible risk 




CHAPTER 1  
INTRODUCTION 
 
 Research background 
Giardia lamblia, also known as Giardia intestinalis and Giardia duodenalis, 
is the only known species from the genus Giardia that can infect humans and a variety 
of animals including the domestic and wildlife animals (Li, Wang, Wang, & Zhang, 
2017). Giardiasis has been recognized as one of the most common intestinal protozoan 
infections worldwide, with over 280 million reported cases per year. Since 2006, 
human giardiasis has been included in the World Health Organization’s (WHO) 
Neglected Diseases Initiative (Perrucci et al., 2019). Giardiasis is prevalent worldwide 
with most of the reported cases are from Asia, Africa, and Latin America. In United 
State, most cases are among returning travellers from Caribbean, Middle East, Eastern 
Europe, Central America, South America, North Africa, sub-Saharan Africa, and 
South-Central Asia (Benedict & Roellig, 2020; Rumsey & Waseem, 2018). 
The pathological outcomes of Giardia infection range from villus- and crypt-
atrophy, enterocyte apoptosis, to severe damage of epithelial barrier function. Some 
clinical studies revealed that there is an association between Giardia infection and the 
development of irritable bowel syndrome and chronic fatigue (Cernikova, Faso, & 
Hehl, 2019). Long-term recurrent exposure to giardia infection is correlated with 
malabsorption among children. Chronic Giardia infection in children has been a major 
health concern as the infection may interrupt their cognitive development and physical 
growth. Poorly developed future generation may hamper the improvement of the local 
socioeconomic (Choy et al., 2014; Trelis et al., 2019). Hence, it is pertinent to discover 
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and eliminate giardiasis in the high-risk populations. This could be done via mass 
surveillance and prompt treatment. 
Risk factors of Giardia infection include low socioeconomic factors, limited 
access to clean water system, poor environmental and personal sanitation (Choy et al., 
2014). Giardiasis is transmitted via faecal-oral route. Although human-to-human 
transmission could happen, humans get infected more commonly upon the ingestion 
of cysts contaminated food or water (Al-Mekhlafi et al., 2013). Transmission via direct 
contact is associated with animal handlers such as farmers and veterinarians because 
domestic livestock are the reservoir of the protozoan, as well. The infection could be 
accidentally acquired as farmers are dealing with the handling of animal faeces (Di 
Piazza et al., 2013). Studies conducted in Bangladesh and in West Bengal, India 
manifested a significant association between Giardia infection in calves and their 
handlers (Ehsan et al., 2015). 
Giardiasis is an endemic protozoal disease in Malaysia. Despite its widespread, 
majority of local studies conducted were limited to aborigines’ population. The figure 
regarding the prevalence and associated risk factors of occupational exposure to 
Giardia infection remain unclear. 
Most of the prevalence studies conducted for giardiasis in developing countries 
are either based on microscopy alone or culture and microscopy as the screening tools. 
However, microscopy method is not preferable to be used for prevalence studies due 
to low sensitivity and detection is limited to current infection. Prevalence study 
conducted by Naz et al., (2018) using microscopic examination was claimed to have 
an inaccurate result due to the low sensitivity of the method. Therefore, the present 
study aimed to investigate the prevalence of Giardia infection among selected cattle 
farmers in Kelantan using serological method. 
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  Rationale of the study 
Giardiasis is a worldwide disease affecting both mammals and humans and it 
has become one of the concerning disease in both developed and developing countries 
including Malaysia. As the life cycle involves the deposition of infectious cysts via 
host excreta into the environment, it poses a risk to humans who work on the field and 
have contact with animals. Occupations such as ruminant livestock farmers including cattle, 
sheep, pigs and horse have been subjected to the risk of getting the infection. It has been 
reported that livestock faeces pose a significant threat to the quality of water sources. 
Contamination may occur directly by faecal deposition or through drainage from the steep 
slopes, heavy rain or flood (Toledo et al., 2017). The use of contaminated water for daily 
activities could post a threat to the farm workers or dwellers (Di Piazza et al., 2013). In 
addition, handling of livestock excreta and cleaning up the farm using untreated water as the 
norm of farmers’ routine tasks exposed the ruminant livestock farm workers to the 
occupational parasitic disease. Until now, there are limited research regarding the prevalence 
of giardiasis in Malaysia, especially in Kelantan, when in fact, Kelantan is considered as one 
of the less industrialize region in Malaysia where most of the populations rely on fishing and 
agriculture (Lim, Ahmad, & Smith, 2008). Besides, most of local studies conducted are limited 
to aborigines’ population. As the disease might affect the quality of health of the farm workers, 
a schedule surveillance is pertinent for inspecting potential under-reporting giardiasis. 
Therefore, the current study will focus on the prevalence of giardiasis in relation to 




 Research objectives 
1.3.1 General objective 
To develop an in-house ELISA for detection of anti-giardia IgG in selected serum 
samples of Kelantan cattle farmers 
 
1.3.2 Specific objectives 
The specific objectives for this study are: 
1. To develop an in-house ELISA for detection of anti-Giardia IgG antibody 
2. To compare the distribution of ELISA OD450nm readings among cattle farmers, 
Orang Asli and blood donors 
3. To determine the association between the anti-Giardia IgG and demographic 






CHAPTER 2  
LITERATURE REVIEW 
 
 Giardia lamblia 
Giardia was first described by Antonie van Leeuwenhoek in 1681 as he was examining 
his own stool samples. Later in 1859, this organism was described in more details by 
Lambl and put the organism in the genus Cercomonas and thus named as Cercomonas 
intestinalis. Kunstler was the first person to name the organism as Giardia in 1882. 
Since the scientists started to discover more Giardia species, they started to name and 
classify the species by host of origin and morphology of the species. Throughout the 
centuries, the organism was given name after a name until Giardia lamblia was 
broadly accepted in the medical and scientific literature (Adam, 2001). To date, there 
are eight species of Giardia that has been identified. They are Giardia agilis, Giardia 
ardeae, Giardia psittaci, Giardia muris, Giardia microti Giardia peramelis and 
Giardia cricetidarum, which infect variety of animals including amphibians, birds, 
rodents and marsupials, and Giardia lamblia which infects broad range of host 
including humans and animals (Ryan & Zahedi, 2019).  
Giardia lamblia genotypes are subdivided into 8 assemblages (A, B, C, D, E, 
F, G, H). Assemblage A and B infect not only human but also pets and livestock 
animals. Assemblage C and D infect dogs, cats, coyotes and wolves, while assemblage 
E infects livestock, assemblage F in cats, whereas assemblage G and H are found in 
rats and marine animals respectively (Fantinatti, Bello, Fernandes, & Da-Cruz, 2016; 
Gutiérrez, 2017). Study conducted by (Anuar, Azreen, Salleh, & Moktar, 2014) 
showed that infection with assemblages A and B were not significantly linked with 
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gender, while infection with assemblage B was found to be significantly higher in 
teenagers with age of below 15 years old. 
 
2.1.1 The Giardia life cycle 
The life cycle of Giardia lamblia simply alternates between trophozoites that are able 
to multiply rapidly and cysts that are environmentally stable. Cyst is the infective stage 
and infection occurs through ingestion of the cysts, followed by excystation, release 
of the excyzoite and trophozoites colonization of the small intestine (Svärd, Hagblom, 
& Palm, 2003). Upon ingestion, cysts pass through the stomach and undergo 
excystation in the small intestine, where the mature cysts transform into trophozoites. 
The excystation is triggered by gastric acid, bile and trypsin in the duodenum 
(Einarsson & Svärd, 2015). Trophozoites colonize the duodenum and jejunum of the 
small intestinal epithelium and multiply rapidly, causes clinical diseases in human 
(Klotz & Aebischer, 2015). During this stage, the trophozoites must adapt to various 
abiotic factors including pH, oxygen tension, the normal bacterial flora, the mucus 
layer as well as intestinal proteases. Besides, they are exposed to destructive factors 
such as T cells, mast cells, M cells, dendritic cells, antibodies, and cytokines. The 
ability of Giardia to withstand these adaptive responses is a crucial determinant for 
them to reproduce and survive (Rópolo & Touz, 2010). Giardia lamblia reproduces 
asexually by binary fusion, however, studies also suggested that they are capable of 
reproducing sexually (Li et al., 2017). A large number of the multiplying trophozoites 
are transported to the colon while undergoing encystation along the way as they are 
exposed to the bile salts and other stimuli as well as elevated pH in the lower part of 
the small intestine (Einarsson & Svärd, 2015). The cysts are then excreted in the faeces 
and continued another infectious cycle when ingested by a new host. Since Giardia 
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lamblia cysts able to withstand environmental degradation, they can remain infectious 
for up to months (Naz, Nawaz, Rasool, & Zahoor, 2018). Cysts infectivity decreased 
by 11% after 49 days at 4°C in soil, and become non-infective after 7 days at 25°C. 
Meanwhile, cysts remain infectious for up to 56 days at 0°C to 4°C and 14 days at 
20°C to 28°C in tap water. They can stand longer in river water with 84 days of 
infectivity at 0°C to 4°C and 28 days at 20°C to 28°C (Feng & Xiao, 2011). 
 
2.1.2 Distribution of Giardiasis 
Giardia lamblia is prevalence worldwide with an estimated 280 million cases per year. 
About 200 million of cases in Asia, Africa and Latin America have symptomatic 
giardiasis (Cacciò & Ryan, 2008). Changes in natural and anthropogenic factors 
largely contribute to the emergence of Giardia lamblia infection (Lee et al., 2017). 
The warm and humid climate may favour survival of Giardia cysts (Ehsan et al., 
2015). This parasite has contributed for 40.6% of 315 of the parasitic waterborne 
outbreaks worldwide (Lee et al., 2017). The prevalence rates for giardiasis in 
developing countries are 8-30% (Deng et al., 2017). Meanwhile, in developed 
countries, the prevalence rates are lower, ranges from 2% to 5%. Most of the cases 
accounted for children under 10 years of age, especially those who are malnourished 
(Naz et al., 2018). In United Kingdom, 1.3% of reported cases are from asymptomatic 
infection in children, 1.4% of cases are among general practitioner population and 
0.9% coming from general population. In England and Wales, there are between 3000-
4000 reported cases every year (Waldram, Vivancos, Hartley, & Lamden, 2017). In 
developed countries, giardiasis is frequent among travellers coming from developing 
countries (Gutiérrez, 2017). According to Feng and Xiao (2011), the infection rates in 
countries such as Germany, United States, Portugal, Belgium and South Korea are low, 
8 
 
ranges from 1.1-4.0%. Meanwhile, Italy, Spain, Saudi Arabia, Australia and New 
Zealand have a slightly higher infection rates, ranges from 0.4-7.6%. A point 
prevalence survey conducted among orphans in Thailand showed a prevalence of 20%. 
The giardiasis prevalence in Jordan is 36% through a study conducted among primary 
school children (Mohamed, Hassan, Hassan, & Rahman, 2008). Infection rates for 
countries in Asia (Bangladesh, Cambodia, China, India, Indonesia, Laos, Malaysia, 
Nepal, Philippines, Thailand, Turkey, Saudi Arabia, and Vietnam), North America 
(Cuba, Mexico, and Nicaragua) and Africa (Northern Africa, West Africa, and South 
Africa) ranging from 8% to 30%, where most of the studies subjected on children 
(Feng & Xiao, 2011). In addition, studies have documented high cases of human 
giardiasis in country such as Italy, the Netherlands, Spain, Brazil and Turkey (Table 
2.1). 
In Malaysia, giardiasis is prevalence among indigenous communities with 
5.5% to 28.3% from overall studies conducted. Higher prevalence rate is observed 
among the Senoi tribe (12.2%) compared to Proto-Malay tribe (3.5%). However, later 
studies showed a vice versa result where prevalence of the Proto-Malay (33.3% of 150; 
10.8% of 268) is found to be higher than Senoi tribe (10.4% of 211; 9.6% of 551) (Lee 






Table 2.1 Prevalence of Giardia lamblia in humans 
 
Source: The table is adopted from Caccio` and Ryan (2008) 
10 
 
2.1.3 Route of transmission of Giardia lamblia  
Giardia lamblia transmits via fecal-oral route through direct or indirect ingestion of 
infectious cysts. Humans are easily infected, indirectly when ingesting food or water 
contaminated with the cysts. These usually occur through the ingestion of raw food, 
unboiled water or acquired from unwashed hand (Haider et al., 2013). Besides, 
infection can spread directly via person-to-person through oral-anal contact (sexual 
transmission) (Gutiérrez, 2017). 
Animal reservoirs crucially contribute to the transmission of different 
assemblages of Giardia lamblia. Stray animals favour the dissemination of the 
infectious cysts as they wander to places. Meanwhile, infected pet may transmit the 
cysts within their surrounding such as the pet owner or other domestic mammalian. In 
addition, infection can easily disseminate in crowded places, including nursery and 
orphanages (Fantinatti, 2019). 
Outbreaks have been associated with drinking of contaminated water and food, 
and contact with contaminated swimming and wading pools. Study in the UK revealed 
that giardiasis cases are implicated with swallowing water while swimming, 
recreational contact with fresh water, drinking tap water and eating green salad. Salad 
may be contaminated when they are washed with contaminated water or handled by 
infected person (Espelage, an der Heiden, Stark, & Alpers, 2010). Infection among 
Orang Asli in Malaysia are mostly due to ingestion of raw vegetables such as tapioca 




2.1.4 Morphology / characteristics of Giardia lamblia 
 
Giardia can exist in two distinct forms the cysts and the trophozoites. The cysts 
of Giardia lamblia are oval in shape, possess four nuclei (quadrinucleated) and a tough 
hyaline cyst wall that responsible for their survival outside host environment. Giardia 
lamblia cyst measures about 11–14 by 7–10 μm and each cyst can transform into two 
trophozoites. Actively swimming Giardia lamblia trophozoites, like the falling leaves 
can be seen when viewed under microscope (Gutiérrez, 2017). The trophozoites have 
a size of about 12 to 15 mm long and 5 to 9 mm wide. The morphology of the 
trophozoites are considered unique as they look similar to the shape of a pear, possess 
of two identical nuclei located symmetrically at the anterior part. An adhesive disc at 
the ventral of the cell surface are responsible for attachment to host intestinal epithelial. 
Besides, Giardia trophozoite also has a claw-shaped median bodies and four pairs of 
flagella located at the anterior, posterior, caudal and ventral (Figure 2.1). The adhesive 
disc is crucial for the virulence of Giardia lamblia (Adam, 2001; Al Saad & Al 
Emarah, 2014). Meanwhile, the Giardia median body protein (MBP) is an adhesive 
disc protein which is essential during cell attachment to the host (Woessner & Dawson, 
2012). Figure 2.1 and Figure 2.3 respectively show the cyst and trophozoite of Giardia 











Source: Adopted from (Faubert, 2000) 
 

















Source:Adopted from Hawrelak (2003) 
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 Clinical manifestation 
Human giardiasis shows a wide range of presenting sign, where infected patient may 
show no symptom or they may present with acute to chronic diarrheal that come along 
with abdominal pain, nausea, dehydration, vomiting and weight loss (Ferreira et al., 
2013). To date, there is no clear explanation on asymptomatic human infection. 
Assumptions have been made whether the person is infected with non-pathogenic 
strains or the parasites not completely eliminated from the host, but is maintained at a 
subclinical level. In most cases, Giardia infections are self-limiting, especially among 
healthy individuals (Espelage et al., 2010). However, some individual may suffer post-
infection symptoms such as irritable bowel and chronic fatigue syndrome, arthritis and 
allergies (Lalle & Hanevik, 2018). 
The incubation period for acute giardiasis is 9-15 days. Patient may suffer with 
intestinal discomfort, anorexia and nausea which subsequently causes prolonged 
diarrhea. Symptoms such as fever and chills followed by watery, foul-smelling, 
explosive diarrhoea may last for 3-4 days or persevere for months if left untreated 
(Haider et al., 2013). Malaise, lassitude, occasional headache as well as malabsorption 
syndrome have been reported in chronic infection. Symptoms developed differ for 
each person, depending on the inoculum size, infection period, and individual host and 
parasite factors. Other than that, symptoms such as urticaria, constipation, 
cholecystitis, pancreatitis, retinal arteritis and iridocyclitis are observed in chronic 




2.2.1 Long term consequences of giardiasis 
Recently, patients infected with Giardia are associated with long-term extra-intestinal 
complications including ocular complications, allergies, muscular complication, and 
metabolic consequences such as nutritional consequences, failure to thrive, stunting 
and impaired cognitive function (Halliez & Buret, 2013). 
 
2.2.1 (a) Ocular complications 
Ocular complications have been reported to be associated with giardiasis. This include 
iridocyclitis, choroiditis, and retinal haemorrhages. Recent studies described a “salt 
and pepper” degeneration associated with the retinal pigmented epithelium in children 
suffering from giardiasis (Figure 2.4). Damage to the cells of the retina along with 
release of pigment granules in retinal layer are believed to promote the formation of 
ocular lesions. However, there is no evidence of direct invasion by the parasite, 
instead, it may be the result of toxic metabolites produced by the parasites (El-Sayed 











Source:Adopted from El-Sayed and Safar (2015) 
 





2.2.1 (b) Arthritis  
Several case study have reported the association between giardiasis and reactive 
arthritis or joint pain. However, there is little evidence to support this claim and the 
magnitude of post-giardiasis arthritis is not known. Until now, there is no large-scale 
epidemiological studies conducted to assess the association between these two 
diseases. Recent retrospective cohort study conducted in United State supported the 
claim of the association between giardiasis and subsequent development of joint pain 
(Painter, Collier, & Gargano, 2017). 
Post-infectious arthritis has a tendency to occur around the joints of the lower 
limbs especially the knee and ankle. Post-infectious reactive arthritis is listed as a 
classical spondyloarthropathy which linked with human leukocyte antigen (HLA)-
B27, the major histocompatibility complex class Ⅰ allele present in half of the cases of 
patients with enteric-infection-related arthritis (Halliez & Buret, 2013). 
 
2.2.1 (c) Muscular complications 
Hypokalaemia myopathy is known to be associated with coeliac disease, radiation 
enteritis and infections. Several cases have been reported in which giardiasis induce 
hypokalaemia in both immunocompromised and immunocompetent patients. This is 
evident that Giardia infection can cause muscular complications regardless of the 
immune status of the host. Loss of potassium is associated with the frequency of bouts 
of diarrhoea per day during the infection (Kanokwanvimol, 2017). Potassium loss 
causes hypokalaemia which can lead to severe and transient myopathy. Hypokalaemia 
induced by giardiasis is frequent among elderly, especially among women. However, 
giardiasis-associated hypokalaemia rarely trigger myopathy and the causes of such 
complications is still not clear. Suggested mechanism is through the impairment of 
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nutrient and electrolyte absorption during giardiasis that is thought to play small part 
in causing hypokalemia and hyponatremia (Halliez & Buret, 2013). 
 
 Pathophysiology of intestinal giardiasis 
Over the year, it has been revealed that various factors involved in the pathophysiology 
of giardiasis which include parasitic, host, dietary, and environmental factors, as well 
as immunological and non-immunological processes. Acute giardiasis has been 
associated with increase rate of enterocyte apoptosis. In vitro studies revealed a 
significant upregulation of genes involved in the apoptotic cascade and formation of 
reactive oxygen species through parasite-host interactions. Another finding discovered 
the involvement of caspase-3 activation, PARP, cleavage, decreased expression of 
anti-apoptotic Bcl-2, and upregulation of pro-apoptotic Bax in Giardia-induced 
apoptosis in human epithelial cells. Besides, consumption of host arginine by Giardia 
eliminates the substrate needed for the production of nitric oxide by the enterocytes. 
Nitric oxide is crucial for the inhibition of giardial growth (Buret, 2008). 
Disruption of the intestinal barrier function is also one of the 
pathophysiological stage involves during acute giardiasis. Some cases have been 
reported among patients with chronic infections. Both in vivo and in vitro studies have 
demonstrated that Giardia parasite caused an elevated intestinal permeability during 
peak of trophozoites colonization. In addition, there are reports that observed an 
increasing uptake of macromolecules in the jejunum of animal models caused by 
Giardia infection, which also occurs during the peak of trophozoites colonization 
(Cotton, Beatty, & Buret, 2011). Giardia-mediated alteration of intestinal permeability 
result from alteration of the tight junctional complex, apoptosis of epithelial cell, and 
l-arginine starvation. Giardia damages the epithelium structure by disrupting the 
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apical junctional complex (AJC) between enterocytes which composed of tight 
junctions (TJ), adherent junctions and desmosomes. AJC functions as a selective 
barrier that protect sub-epithelial compartments from the luminal environment. 
Giardia disrupts the zonula occludens-1 and 2 proteins (ZO-1; ZO-2) which are 
elements of the TJ. Giardia also causes damage to the epithelial occludin and claudin-
1, disruption of apical filamentous actin (F-actin) in the cytoskeleton as well as 
rearrangement of α-actinin which also promotes to the disruption of the AJC. Claudin 
proteins are crucial element which function as sealing properties of the tight junctions. 
Disruption of epithelial permeability by epithelial apoptosis implicates the disruption 
of cellular ZO-1 (Allain, Amat, Motta, Manko, & Buret, 2017). 
In addition, giardiasis is known to cause diffuse shortening of brush border 
microvilli. Diffuse shortening of brush border microvilli leads to malabsorption as 
mucosal surface area for water, nutrient, mineral, vitamin A and B12 absorption as 
well as electrolyte transport are reduced. Disruption of microvilli is also linked with 
decreased activity of brush border digestive enzymes such as disaccharidases, and 
Na/D-glucose malabsorption. Both diffuse shortening of brush border microvilli and 
microvillar disaccharidase deficiencies are mediated by activated CD8+ lymphocytes 




 Treatment of giardiasis 
The standard treatment used against giardia infection consists of pharmaceutical drugs. 
Nitroimidazole is considered as the first-line drug in treating giardiasis, with 
metronidazole as one of the most commonly prescribed. Other drugs drawn from this 
structural class include tinidazole, secnidazole and ornidazole (Carter, Nabarro, 
Hedley, & Chiodini, 2018). Metronidazole (commercially known as Flagyl) not only 
included in the 2015 WHO Essential Medicines List9 but also become the only anti-
giardial drug advised by Public Health England (PHE). Recently, tinidazole has been 
accepted by UK and USA health authorities (Ordóñez-Mena, McCarthy, & Fanshawe, 
2018). Metronidazole and tinidazole have a successful treatment rate of 80-90% 
(Abraham et al., 2019). Mechanism of action of metronidazole utilizes the anaerobic 
metabolic pathways in the Giardia. Metronidazole becomes activated when they are 
reduced to nitroso radicals. Reduced metronidazole then binds to DNA 
macromolecules, free thiols or protein cysteines causes DNA damage as they loss their 
helical structure, damage to the template function, strand breakage, arrest of cell cycle 
progression and oxidative stress which lead to trophozoites death (Gardner & Hill, 






Table 2.2 Mechanism of action of drugs used to treat Giardia infection 
 
Source: Adopted from Carter et al., (2018)
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Albendazole (benzimidazole) is a well described alternative giardiasis 
treatment, known to paralyze the parasite by producing the reactive species, 
particularly in the nuclei causes oxidative stress and DNA damage. In addition, 
albendazole has an efficacy rate of such similar to the 5-nitroimidazoles family. Other 
alternative agents include nitazoxanide, paromomycin, quinacrine, furazolidone and 
mebendazole. A study revealed that nitazoxanide has 78% of parasitologic cure rate 
when used as first-line treatment in children. Nevertheless, data on its use for 
refractory cases are still limited (Abraham et al., 2019; Carter et al., 2018). Despite 
their effectiveness, these drugs have been reported to manifest side effects such as 
nausea, fatigue and malaise. Metronidazole is potentially carcinogenic and is not 
suitable to be prescribed for pregnant patient, especially in their first trimester. 
Alternatively, furazolidone can be given for this group of patients as this drug is the 
least teratogenic among the other options (Vesy & Peterson, 1999). 
Recent findings suggested albendazole-metronidazole combination therapy is 
more effective in treating refractory giardiasis compared to albendazole alone, 
suggesting a synergistic effect. Even so, regardless of the agents, most of giardial 
therapy does not achieve 100% of cure rates. Recently, the number of nitroimidazole-
refractory cases reported has been increasing especially among returning travellers 
from Asia. Such infection has been associated with drug resistance, suboptimal drug 
concentrations, reinfection, immunocompromised state and immunoglobulin A 
deficiency. Reports have been made that some patients exhibit metronidazole-
resistance against Giardia infection causes failure in the treatment. Resistance to 
metronidazole has been suggested to be associated with impaired mucosal attachment 
causes reduced parasite fitness. Meanwhile, a combination of adapting energy supply, 
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albendazole metabolism reduction and increased cysteine and antioxidant enzymes 
which increased tolerance to oxidative stress may be the principle for albendazole 
resistance (Carter et al., 2018). Table 2.3 shows the drugs and their adverse effects, 
pharmacokinetics and interactions of drugs used to treat giardiasis. Considering these 
limitations, it is important to continue the research for new effective anti-giardial drug 
candidates.  
 
